Export 47 results:
Autore Titolo Tipo [ Anno(Desc)]
Filtri: First Letter Of Title è N  [Clear All Filters]
2012
Pontillo A, Catamo E, Arosio B, Mari D, Crovella S. NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26(3):277-81.
Carinci F, Monasta L, Rubini C, Stramazzotti D, Palmieri A, Melloni E, Knowles A, Ronfani L, Zauli G, Secchiero P. The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. Invest New Drugs 2012;30(2):810-8.
Kido ÉAkio, Neto JRibamar Co, Silva RLane de Ol, Pandolfi V, Guimarães ACarolina R, Veiga DTruffi, Chabregas SMoutinho, Crovella S, Benko-Iseppon AMaria. New insights in the sugarcane transcriptome responding to drought stress as revealed by superSAGE. ScientificWorldJournal 2012;2012:821062.
Gasparini C, Feldmann M. NF-κB as a target for modulating inflammatory responses. Curr Pharm Des 2012;18(35):5735-45.
Girardelli M, Maestri I, Rinaldi RR, Tognon M, Boldorini R, Bovenzi M, Crovella S, Comar M. NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. Infect Agent Cancer 2012;7(1):25.
di Iasio MGrazia, Addobbati R, Radillo O, Voltan R. Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples. Invest New Drugs 2012;30(4):1761-5.

Amministrazione Trasparente